Alan H Bryce
763 posts
Alan H Bryce
@AlanBryce9
Medical oncologist and cancer researcher specializing in Prostate Cancer. Chief Clinical Officer, City of Hope Arizona, Professor of Molecular Medicine,Tgen
Phoenix, AZ Beigetreten Temmuz 2019
622 Folgt1.3K Follower
Rage, rage against the dying of the light…
False spring #6 this year in Rochester.
How was your commute home from work…?
English
@scserendipity1 @brookmans76 @SimonMDLord @lauren_henke @TylerSbrt7 @DrYukselUrun @aadel_chaudhuri @_ShankarSiva @cwspeers @shiv_smith @ResearchWyatt @mleapman @PaulSargos @SimonLo21054188 @NiuSanford @alison_tree @AlisonBirtle @VedangMurthy @HimanshuNagarMD @andreasroder1 @CZamboglou @swoo_rad @AdamSharpMedOnc @sophia_kamran @HenningWillers @OHSUKnight Sadly my cycling days are long past. AZ indeed has fluffy clouds but also drivers who regard cyclists as pests to be removed from the road. Makes me miss Minnesota summers.
English
@brookmans76 @SimonMDLord @lauren_henke @TylerSbrt7 @DrYukselUrun @aadel_chaudhuri @_ShankarSiva @cwspeers @shiv_smith @ResearchWyatt @mleapman @PaulSargos @SimonLo21054188 @NiuSanford @alison_tree @AlisonBirtle @VedangMurthy @HimanshuNagarMD @andreasroder1 @CZamboglou @swoo_rad @AdamSharpMedOnc @sophia_kamran @HenningWillers @OHSUKnight Great photos. Love the little fluffy clouds… Arizona like @AlanBryce9
m.youtube.com/watch?v=8Ecdn5…
English
Oncology friends 🌍🌏🌎
🙏🏼 share 📸 while out 🏃🏼🏃🏽♀️🚶🏿♂️🚴🏾♀️⛷️🏂🏄🏽♀️
🌊🏝️☀️🏔️🌳🌻🌧️❄️
🏃🏼by💧
@aadel_chaudhuri @scserendipity1 @_ShankarSiva @SimonMDLord @ethansgrumps @cwspeers @shiv_smith @lauren_henke @ResearchWyatt @mleapman @PaulSargos @SimonLo21054188 @NiuSanford @alison_tree
Tyler Seibert - tmp account. Go follow @TylerSbrt@TylerSbrt7
🥇First post with new account has to be:🏃🏼 by 💧 #EAU26 (#ProstateCancer #radonc content coming soon)
English
@scserendipity1 @Arsenal @_DeclanRice That would amazing. Obviously Declan Rice is his favorite player and Arsenal are his favorite team. He’s a Gooner through and through.
English
English
Scotland v Japan match today. Thank goodness it’s a friendly!!
English
@scserendipity1 We support both squads so this is difficult!
My Zlatan Bryceahimovic had 1 goal and 1 assist in a 3-3 draw today. His man bun was flying around the field.
English
@AlanBryce9 I’m presuming we are supporting Scotland! Declan ‘Zlatan’ Bryce got his kilt on?
English
25% discordance between PSA and radiographic progression is also what we saw in PREVAIL and CHAARTED so the finding is clearly consistent. If it feels high that is likely because your real world definition for PSA progression is more liberal.
nature.com/articles/pcan2…
sciencedirect.com/science/articl…
Simon C@scserendipity1
I did struggle with this despite being kindly involved in some of the studies. 25% feels high but anecdote versus data never a good thing. @Prof_IanD @ChrisSweens1 guide me. No PSA progression but LDH, LFTs, FBC, Albumin. Would they miss this? It’s clearly more than I feel clinically which would be closer to 10% @Silke_Gillessen @alison_tree @AdamSharpMedOnc @AlanBryce9
English
Congratulations my friends. This is a wonderful concept.
Gianrico Farrugia@GFarrugiaMD
A new study evaluating Mayo’s Cancer CARE Beyond Walls program highlights how home-based chemotherapy can reduce the burden of cancer treatment while improving patients’ quality of life. catalyst.nejm.org/doi/full/10.10…
English
Alan H Bryce retweetet
Consensus recommendations for PSMA PET imaging in metastatic #ProstateCancer. @TDorffOnc @cityofhope joins @AlanBryce9 breaking down key takeaways from the US Prostate Cancer Consensus Conference—tackling real-world gray areas in imaging and treatment. Highlights include when to use PSMA PET vs conventional imaging, guidance on prostate radiation in low-volume mCSPC, and when metastasis-directed therapy fits for oligometastatic #mCRPC. #WatchNow on UroToday > bit.ly/4jPAX07
English
@scserendipity1 @cityofhope @MedicalwatchHQ Great to see you @scserendipity1, and great win by @manutd. Go Reds!
English
@AlanBryce9 great to see you @cityofhope Is it time for Declan to change clubs? Love to the family and thanks for friendship and guidance @MedicalwatchHQ
The football boy@thefutballboy_1
🚨Zlatan Ibrahimovicc “Watching Sesko play football reminds me of myself, he’s a replica, he’s tall, can dribble, can jump and he also have great link up play, most tall strikers can’t do that, Manchester has got a generational goal Machine.”
English
@OncUpdates @DrKarineTawagi @OncBrothers @cityofhope @SignifyMD Thanks for having me. Always a pleasure to work with the @OncBrothers and @DrKarineTawagi. I’m amazed by how thoroughly the @oncbrothers are able to cover hot takes across the entire fist two days of GUASCO
English
🎥Next up, @AlanBryce9 and @DrKarineTawagi discuss updates in #ProstateCancer
Key Study Highlights:
⭐️PEACE2
⭐️PSMAddition
⭐️CAPItello-281
⭐️PEACE3
⭐️BRCAAway
@OncBrothers #MedTwitter #OncTwitter #AdvInOnc26 #gusm #GU26 #FOAMed #MedEd #CancerResearch #Oncology @cityofhope
English
Spring Training is one of the great things about living in Arizona. My family looks forward to it every year. Go Guardians!
English
Thank you to @CleGuardians. Today is the first day of Spring Training and they are raising money to support cancer care at @cityofhope.
English
@allisonoconn @ReneeSaliby It’s recommended for all metastatic, not just de novo. While that is clearly implied by the second category, I think the inclusion of the term de novo may create confusion here.
English
Today I learned germline genetic testing is recommended for prostate cancer patients if they’re:
1. De novo metastatic
2. High risk or very high risk
3. Intermediate risk with either a family history or intraductal carcinoma on pathology.
English
@TylerSbrt @scserendipity1 @SimonLo21054188 @lauren_henke @aadel_chaudhuri @cwspeers @andreasroder1 @brookmans76 @_ShankarSiva @ResearchWyatt @shiv_smith @SimonMDLord @RenuEapen @AlisonBirtle @mrsprostate @alison_tree @MariamAboian @sophia_kamran @HimanshuNagarMD @JuanMiguelPechL @ethansgrumps @swoo_rad @Prof_Nick_James @Papa_Heme @DrChoueiri @dr_coops @doclauravater @DrCols @MAWildgust Merry Christmas my friends
English
Alan H Bryce retweetet
Efficacy of rucaparib vs physician’s choice in patients with BRCA-mutated metastatic castration-resistant #ProstateCancer by age: Results from the #TRITON3 study. Presentation by @AlanBryce9 @MayoClinic. #SUO25 written coverage by @chavarriagaj @PSH_Urology > bit.ly/3Ks2F5Y @UroOnc
English
Same. This is an article I have shared with countless residents and fellows over the years. Also, the poem Otherwise that he references is part of our family tradition where I have my boys read poetry to their mother.
Ramy Sedhom, MD, FASCO@ramsedhom
A favorite read, I find myself revisiting time and time again @DavidSteensma - the loss of our patients is a hard part of oncology & it is important to take pride in caring so well for those who die ascopubs.org/doi/full/10.12…
English
Alan H Bryce retweetet
Comparative Survival in Metastatic Hormone-sensitive Prostate Cancer by Volume of Disease and Timing of Metastasis: A Living Network Meta-analysis
sciencedirect.com/science/articl…
This living network meta-analysis of 11 phase 3 trials shows that treatment benefits in metastatic hormone-sensitive #ProstateCancer differ by disease volume and timing. Triplet therapy (ARPI + docetaxel + ADT) offers the greatest survival advantage only in patients with synchronous high-volume disease. For all other subgroups—synchronous low-volume, metachronous high-volume, and metachronous low-volume—ARPI + ADT alone is the preferred option and outperforms ADT alone or docetaxel + ADT, with no clear added benefit from adding docetaxel when ARPIs are available.
Irbaz Bin Riaz
@PrafulRavi1
@Parminder1699
@neerajaiims
@amerseburger
@AarmstrongDuke
@BertrandTOMBAL
Karim Fizazi
@AlanBryce9
@OncoAlert 🚨
@Silke_Gillessen
@AOmlin
@nataliagandur
English
Alan H Bryce retweetet
Just in @EUplatinum 👉Big congrats to @IrbazRiaz & team for this superb meta-analysis! 👏 Their living meta analysis framework shows how digital tools e.g. AI/LLMs set a new standard for timely synthesis k sharing of the evidence. @AlanBryce9 @OncoAlert @urotoday @PCF_Science
Advanced Prostate Cancer Consensus Conference@APCCC_Lugano
Comparative Survival in Metastatic Hormone-sensitive Prostate Cancer by Volume of Disease and Timing of Metastasis: A Living Network Meta-analysis sciencedirect.com/science/articl… This living network meta-analysis of 11 phase 3 trials shows that treatment benefits in metastatic hormone-sensitive #ProstateCancer differ by disease volume and timing. Triplet therapy (ARPI + docetaxel + ADT) offers the greatest survival advantage only in patients with synchronous high-volume disease. For all other subgroups—synchronous low-volume, metachronous high-volume, and metachronous low-volume—ARPI + ADT alone is the preferred option and outperforms ADT alone or docetaxel + ADT, with no clear added benefit from adding docetaxel when ARPIs are available. Irbaz Bin Riaz @PrafulRavi1 @Parminder1699 @neerajaiims @amerseburger @AarmstrongDuke @BertrandTOMBAL Karim Fizazi @AlanBryce9 @OncoAlert 🚨 @Silke_Gillessen @AOmlin @nataliagandur
English
English
We’re thrilled to welcome @adapthyun to @COH_RadOnc! Dr. Hyun Kim is an internationally-recognized thought leader in GI cancer, adaptive radiation therapy & radiopharmaceuticals, and will lead our GI RadOnc & #theranostics programs. #radonc @cityofhope @NRGonc @ASTRO_org
English